Drug Delivery Technology Market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period.

Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the drug delivery technology market. Furthermore, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.

The drug delivery technology market is segmented based on route of administration, facility of use, and region. On the basis of route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosa. The topical drug delivery segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can primarily be attributed to the factors such as convenience and ease of use, ease of dosage, painlessness, noninvasiveness, and enhanced patient compliance.

                                           Download the PDF Brochure@ http://bit.ly/2SDbz03

On the basis of facility of use, the market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to advantages such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool.

Asia is projected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

The drug delivery technology market is highly competitive market with various players. Prominent players in this market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).

                                    You Can Also Get the Sample Pages@ http://bit.ly/2RwZ3lz

Target Audience:

• Drug Delivery Technology Manufacturers
• Public and Private Physicians
• Healthcare Institutions (Medical Data Centers)
• Research & Clinical Laboratories
• Distributors and Suppliers of Drug Delivery Technologies
• Health Insurance Payers
• Market Research and Consulting Firms

Scope of the Report

This report categorizes the drug delivery technology market into the following segments and sub-segments.

Drug Delivery Technology Market, by Route of Administration

• Oral
• Injectable
• Topical
• Ocular
• Nasal
• Pulmonary
• Transmucosal
• Implantable

Drug Delivery Technology Market, by Facility of Use

• Hospitals
• Ambulatory Surgical Centers
• Home Care settings
• Diagnostic Centers
• Other Facilities of Use

Drug Delivery Technology Market, by Region 

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe (RoE)
• Asia
  • China
  • India
  • Japan
  • Rest of Asia (RoA)
• Rest of the World (RoW)

Read More:
https://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html